Posttransplant diabetes mellitus and long-term outcomes after kidney transplantation in a steroid avoidance regimen: a cohort study

No Thumbnail Available

Authors

Gardiner,Claire;Keane,David;Ho,Eva;Lenfant,Virginie;Tankisi,Ozlem;Yam,Michelle Hiu Ching;Daga,Sunil

Issue Date

2025

Type

Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

BACKGROUND: Posttransplant diabetes mellitus (PTDM) is associated with reduced patient survival and death-censored graft survival and has been linked to steroid use and obesity. Steroid avoidance regimens have been associated with a reduction in PTDM without impacting patient or graft survival followed up for 5 years following kidney transplantation; however, acute rejection remains a concern. The primary objective of this study was to assess death-censored graft and patient survival outcomes and report on PTDM onset in patients receiving steroid-avoidance immunosuppressant regimens over 11 years. METHODS: This was a retrospective cohort study from a single center in the UK that included first kidney transplants between 2010 and 2021. Logistic regression models and Cox proportional hazards models were used to investigate associations between survival and PTDM. A P value < 0.05 was considered to indicate statistical significance. RESULTS: There was no difference in patient or graft survival among those with PTDM, preexisting diabetes or no diabetes. 16% (n = 55) developed PTDM over a median follow-up of 7.1 years (range: 0.9–13.8 years). After adjusting for confounding factors, the odds of PTDM diagnosis were associated with increasing BMI (odds ratio (OR): 1.01; 95% CI: 1.03–1.18), and white ethnicity was associated with reduced odds of PTDM (OR: 0.45; 95% CI: 0.23–0.90). CONCLUSIONS: Our findings support lower PTDM rates and safe longer-term outcomes following a steroid-free regimen. Timely weight management interventions before transplantation, particularly in high-risk groups, may reduce PTDM in this population. CLINICAL TRIAL NUMBER: Not applicable. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-025-04419-2.

Description

Citation

Publisher

License

Journal

BMC nephrology

Volume

26

Issue

1

PubMed ID

DOI

ISSN

EISSN

Collections